Trial Profile
Drug use-results survey on safety and efficacy of Rupafin tablets 10 mg
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Allergic rhinitis; Eczema; Pruritus; Urticaria
- Focus Adverse reactions; Therapeutic Use
- Sponsors Teikoku Seiyaku
- 01 Mar 2021 Status changed from active, no longer recruiting to completed.
- 01 Apr 2020 Status changed from recruiting to active, no longer recruiting.
- 19 Feb 2018 New trial record